Recruiting
Drug, Other intervention and Procedure for Glaucoma, Open-Angle, sponsored by Allergan
Get in touch This trial recruits from August 2015 for 148 weeks
Allergan Inc.
Email: clinicaltrials@allergan.com
Inclusion Criteria
Age: From 18 Years To N/A
Gender: Both
Inclusion Criteria
Diagnosis of either Open-Angle Glaucoma or Ocular Hypertension in each eye that require IOP lowering treatment.
Exclusion Criteria
Eye surgery (including cataract surgery) and or eye laser surgery within the past 6 months.
Enrollment in other studies using Bimatoprost SR.
Exclusion Criteria
NCT02507687
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension